In this wide-ranging podcast interview with Josh Long, INSIDER's legal editor, Venable attorneys Michelle Jackson and Michael Blume—a former official with the U.S. Department of Justice (DOJ)—discuss:
-- Factors that influenced DOJ’s enforcement sweep announced in 2015 against unlawful activity in the dietary supplement industry;
-- FDA regulations under the Trump administration and 2016 draft new dietary ingredient (NDI) guidance adopted by FDA;
-- Considerations that could result in DOJ not adopting an FDA recommendation to proceed with court action;
-- A pending appeal over the legality of DMAA in dietary supplements; and
-- Recommendations for responding to a government investigation.
Jackson and Blume will be speaking on Tuesday, Sept. 26, during a workshop at SupplySide West in Las Vegas. The workshop “FDA Lawsuits and Class Action Litigation,” will explore FDA’s years-long court battle over the legality of DMAA, regulatory strategies to establish the safety of a new ingredient, an update on class action litigation, and tips to defend against lawsuits brought by regulators and the private plaintiffs’ bar.